Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Apr 04, 2023 11:14am
155 Views
Post# 35378639

RE:Did you all forget the Adlai results?

RE:Did you all forget the Adlai results?
Current data is probably very positive...
Well that is a statement that everyone likes to hear .PROBABALY....
Seems lately that we have to keep convincing ourselves that all is good and that we are going to be a 5-8 billion dollar company and yet for some strange reason our sp is down about 40% from our 3 month high.
The disconnect is what is driving everyone crazy and I know many have said sp does not matter but hard for wrap my head around that one as not even a whisper of rumours.
Bottom line is we now just have to wait it out and hope that Matt anc company are correct in them saying that they want to create shareholder value and that they expect 2 phase 3 trials to be going this year.
Definately need something of worth for a change to save the sp and make all feel at ease and the only thing that is going to do that is a partnership or BO. I do not even think that results alone will do this. It has to be a deal done to finally get things going. BO is preferred IMO but a partnership will at least put the company on solid ground. No more delays ONC.
<< Previous
Bullboard Posts
Next >>